Timing is more important than choice of agent

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1506a (Published 02 December 1995) Cite this as: BMJ 1995;311:1506
  1. Tom Sulkin, Registrar in general medicine
  1. Royal South Hants Hospital, Southampton SO14 0TG

    EDITOR,--Marc Verstraete states incorrectly1 that the accelerated tissue plasminogen activator regimen used in the global utilisation of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) trial2 “lowered the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription